Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne Monosaccharides

Metabolic glycoengineering enables a directed modification of cell surfaces by introducing target molecules to surface proteins displaying new features. Biochemical pathways involving glycans differ in dependence on the cell type; therefore, this technique should be tailored for the best results. We...

Full description

Bibliographic Details
Main Authors: Stephan Altmann, Jürgen Mut, Natalia Wolf, Jutta Meißner-Weigl, Maximilian Rudert, Franz Jakob, Marcus Gutmann, Tessa Lühmann, Jürgen Seibel, Regina Ebert
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/6/2820
id doaj-c7107bc9232a49d9a2c20804bfba11c3
record_format Article
spelling doaj-c7107bc9232a49d9a2c20804bfba11c32021-03-11T00:06:39ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-03-01222820282010.3390/ijms22062820Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne MonosaccharidesStephan Altmann0Jürgen Mut1Natalia Wolf2Jutta Meißner-Weigl3Maximilian Rudert4Franz Jakob5Marcus Gutmann6Tessa Lühmann7Jürgen Seibel8Regina Ebert9Bernhard-Heine-Center for Locomotion Research, University of Würzburg, Friedrich-Bergius-Ring 15, 97076 Würzburg, GermanyInstitute of Organic Chemistry, University of Würzburg, Am Hubland, 97074 Würzburg, GermanyInstitute of Organic Chemistry, University of Würzburg, Am Hubland, 97074 Würzburg, GermanyBernhard-Heine-Center for Locomotion Research, University of Würzburg, Friedrich-Bergius-Ring 15, 97076 Würzburg, GermanyBernhard-Heine-Center for Locomotion Research, University of Würzburg, Friedrich-Bergius-Ring 15, 97076 Würzburg, GermanyBernhard-Heine-Center for Locomotion Research, University of Würzburg, Friedrich-Bergius-Ring 15, 97076 Würzburg, GermanyInstitute of Pharmacy and Food Chemistry, University of Würzburg, Am Hubland, 97074 Würzburg, GermanyInstitute of Pharmacy and Food Chemistry, University of Würzburg, Am Hubland, 97074 Würzburg, GermanyInstitute of Organic Chemistry, University of Würzburg, Am Hubland, 97074 Würzburg, GermanyBernhard-Heine-Center for Locomotion Research, University of Würzburg, Friedrich-Bergius-Ring 15, 97076 Würzburg, GermanyMetabolic glycoengineering enables a directed modification of cell surfaces by introducing target molecules to surface proteins displaying new features. Biochemical pathways involving glycans differ in dependence on the cell type; therefore, this technique should be tailored for the best results. We characterized metabolic glycoengineering in telomerase-immortalized human mesenchymal stromal cells (hMSC‑TERT) as a model for primary hMSC, to investigate its applicability in TERT-modified cell lines. The metabolic incorporation of <i>N</i>‑azidoacetylmannosamine (Ac<sub>4</sub>ManNAz) and <i>N</i>‑alkyneacetylmannosamine (Ac<sub>4</sub>ManNAl) into the glycocalyx as a first step in the glycoengineering process revealed no adverse effects on cell viability or gene expression, and the in vitro multipotency (osteogenic and adipogenic differentiation potential) was maintained under these adapted culture conditions. In the second step, glycoengineered cells were modified with fluorescent dyes using Cu-mediated click chemistry. In these analyses, the two mannose derivatives showed superior incorporation efficiencies compared to glucose and galactose isomers. In time-dependent experiments, the incorporation of Ac<sub>4</sub>ManNAz was detectable for up to six days while Ac<sub>4</sub>ManNAl-derived metabolites were absent after two days. Taken together, these findings demonstrate the successful metabolic glycoengineering of immortalized hMSC resulting in transient cell surface modifications, and thus present a useful model to address different scientific questions regarding glycosylation processes in skeletal precursors.https://www.mdpi.com/1422-0067/22/6/2820hMSC-TERTmetabolic glycoengineeringglycocalyxmodified monosaccharidesclick chemistry
collection DOAJ
language English
format Article
sources DOAJ
author Stephan Altmann
Jürgen Mut
Natalia Wolf
Jutta Meißner-Weigl
Maximilian Rudert
Franz Jakob
Marcus Gutmann
Tessa Lühmann
Jürgen Seibel
Regina Ebert
spellingShingle Stephan Altmann
Jürgen Mut
Natalia Wolf
Jutta Meißner-Weigl
Maximilian Rudert
Franz Jakob
Marcus Gutmann
Tessa Lühmann
Jürgen Seibel
Regina Ebert
Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne Monosaccharides
International Journal of Molecular Sciences
hMSC-TERT
metabolic glycoengineering
glycocalyx
modified monosaccharides
click chemistry
author_facet Stephan Altmann
Jürgen Mut
Natalia Wolf
Jutta Meißner-Weigl
Maximilian Rudert
Franz Jakob
Marcus Gutmann
Tessa Lühmann
Jürgen Seibel
Regina Ebert
author_sort Stephan Altmann
title Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne Monosaccharides
title_short Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne Monosaccharides
title_full Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne Monosaccharides
title_fullStr Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne Monosaccharides
title_full_unstemmed Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne Monosaccharides
title_sort metabolic glycoengineering in hmsc-tert as a model for skeletal precursors by using modified azide/alkyne monosaccharides
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2021-03-01
description Metabolic glycoengineering enables a directed modification of cell surfaces by introducing target molecules to surface proteins displaying new features. Biochemical pathways involving glycans differ in dependence on the cell type; therefore, this technique should be tailored for the best results. We characterized metabolic glycoengineering in telomerase-immortalized human mesenchymal stromal cells (hMSC‑TERT) as a model for primary hMSC, to investigate its applicability in TERT-modified cell lines. The metabolic incorporation of <i>N</i>‑azidoacetylmannosamine (Ac<sub>4</sub>ManNAz) and <i>N</i>‑alkyneacetylmannosamine (Ac<sub>4</sub>ManNAl) into the glycocalyx as a first step in the glycoengineering process revealed no adverse effects on cell viability or gene expression, and the in vitro multipotency (osteogenic and adipogenic differentiation potential) was maintained under these adapted culture conditions. In the second step, glycoengineered cells were modified with fluorescent dyes using Cu-mediated click chemistry. In these analyses, the two mannose derivatives showed superior incorporation efficiencies compared to glucose and galactose isomers. In time-dependent experiments, the incorporation of Ac<sub>4</sub>ManNAz was detectable for up to six days while Ac<sub>4</sub>ManNAl-derived metabolites were absent after two days. Taken together, these findings demonstrate the successful metabolic glycoengineering of immortalized hMSC resulting in transient cell surface modifications, and thus present a useful model to address different scientific questions regarding glycosylation processes in skeletal precursors.
topic hMSC-TERT
metabolic glycoengineering
glycocalyx
modified monosaccharides
click chemistry
url https://www.mdpi.com/1422-0067/22/6/2820
work_keys_str_mv AT stephanaltmann metabolicglycoengineeringinhmsctertasamodelforskeletalprecursorsbyusingmodifiedazidealkynemonosaccharides
AT jurgenmut metabolicglycoengineeringinhmsctertasamodelforskeletalprecursorsbyusingmodifiedazidealkynemonosaccharides
AT nataliawolf metabolicglycoengineeringinhmsctertasamodelforskeletalprecursorsbyusingmodifiedazidealkynemonosaccharides
AT juttameißnerweigl metabolicglycoengineeringinhmsctertasamodelforskeletalprecursorsbyusingmodifiedazidealkynemonosaccharides
AT maximilianrudert metabolicglycoengineeringinhmsctertasamodelforskeletalprecursorsbyusingmodifiedazidealkynemonosaccharides
AT franzjakob metabolicglycoengineeringinhmsctertasamodelforskeletalprecursorsbyusingmodifiedazidealkynemonosaccharides
AT marcusgutmann metabolicglycoengineeringinhmsctertasamodelforskeletalprecursorsbyusingmodifiedazidealkynemonosaccharides
AT tessaluhmann metabolicglycoengineeringinhmsctertasamodelforskeletalprecursorsbyusingmodifiedazidealkynemonosaccharides
AT jurgenseibel metabolicglycoengineeringinhmsctertasamodelforskeletalprecursorsbyusingmodifiedazidealkynemonosaccharides
AT reginaebert metabolicglycoengineeringinhmsctertasamodelforskeletalprecursorsbyusingmodifiedazidealkynemonosaccharides
_version_ 1724226164908621824